Can you treat thyroid cancer with Afatinib? This is one of the most effective treatments for thyroid cancer. It is made from a combination of proteins and is taken by mouth in a pill form. The pill form is easier for the body to digest and therefore makes a faster recovery. However, it is important to note that this is an experimental treatment and has not been approved for general use like BIBW2992.
Afatinib works by inhibiting iodine absorption. Iodine is needed for optimal thyroid health. A hormone produced by thyroid cells, thyroxin, helps carry out this function. When this hormone is interrupted, thyroid cancer can progress. In order to prevent this, iodine must be regularly consumed.
Many people take thyroid hormones for other reasons than to treat thyroid disease. The Food and Drug Administration has approved four drugs for this purpose – clomiphene citrate, inorganic nitric oxide version of levothyroxine, and nodular compounds in its various forms. However, these drugs have some serious effects including bone marrow depression and increased risk of blood clots. Others, such as atenolol and metformin, are approved only for short-term use. Afatinib is approved for long-term use with no known effects.
As for the manufacturer, Generex, is known for its high quality products that are backed by strong clinical studies confirming their efficacy. It has not, however, confirmed any adverse effects. It is a natural product, so effects are unlikely. However, it is recommended to see your doctor before taking it. Do not take Afatinib if you suffer from severe constipation or chronic diarrhea as these are also common effects of this drug.
One important thing to note is that only very late-stage cancers that are unresponsive to standard treatments are appropriate for this form of treatment. This is why most patients who have already been diagnosed with a terminal disease choose to pursue treatment using Afatinib. Other treatment options for advanced cancers include palliative therapy that is focused on relieving symptoms and improving quality of life. It is not intended to improve the outcome of the patient’s cancer.
The exact mechanism through which Afatinib works in response to thyroid cancer is not yet known. It is believed that this drug activates the production of an enzyme called radio sensitivity which subsequently causes cells to be hypersensitive to iodine. Patients who suffer from thyroid cancer frequently receive radioactive iodine treatment after diagnosis. In such cases, Afinib may be useful as an alternative treatment. Results from ongoing studies in this area are being published regularly.